Immunn

CAR T-cell is the future of cancer therapy. Immunn empowers researchers by tracking and predicting patient outcomes, accelerating clinical trials and providing special AI assist for the entire process

Comment

My journey with "Immunn" began by observing a fundamental problem in cancer care. While supporting my grandfather through his treatment for lung cancer, I saw firsthand the limitations of traditional chemotherapy. It was a one-size-fits-all approach—a blunt instrument in an age that promised precision. The process was opaque and inefficient, and it became clear to me that the next great leap in medicine wouldn't just be a new drug, but a better way of developing and delivering treatment.

This experience led me to explore the cutting edge of oncology, which is where I discovered CAR T-cell therapy. It was a complete paradigm shift. Instead of systemic chemicals, here was a "living drug"—a personalized, intelligent therapy engineered from a patient's own cells. The potential was staggering: a future of medicine that is targeted, effective, and tailored to the individual. I saw not just a new treatment, but the foundation for a multi-billion dollar revolution in healthcare.

However, with great innovation comes great complexity. I realized the single biggest barrier to this future is data. The development of these therapies is slowed by fragmented information, disconnected workflows, and immense logistical hurdles. This bottleneck isn't just a challenge; it's the single greatest opportunity in the field.

The vision for Immunn was born from this realization. We are not just building a piece of software; we are building the enabling platform for the entire cell therapy industry. Our vision is to create the essential operating system that accelerates research, streamlines clinical trials, and helps scientists unlock the full potential of these living medicines.

By solving these core data and workflow challenges, we can help make personalized cancer therapy not just a scientific possibility, but a widespread clinical reality. My grandfather's experience opened my eyes to a problem, but it’s the immense opportunity to power the next generation of cures that drives the mission of Immunn forward.

Built With

Share this project:

Updates